Document:

EXHIBIT 10.1

 

AMENDMENT TO

 

STOCK PURCHASE AGREEMENT

 

This Amendment
(this “Amendment”) to Stock Purchase Agreement is made as of December 23, 2013 (the “Effective Date”) by
and among Reven Housing REIT, Inc., a Colorado corporation (the “Company”), and the purchasers identified on the signature
pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

 

Recitals

 

A.Reference is
made to that certain Stock Purchase Agreement dated September 27, 2013, by and among the Company and the Purchasers (the “Agreement”)
in connection with the private placement of the Company’s common stock.

 

B.The parties wish
to amend the Agreement to extend the date by which any Subsequent Closings need to occur.

 

Agreement 

 

NOW, THEREFORE, in
consideration of the above recitals and for other good and valuable consideration, the receipt and adequacy of which are hereby
acknowledged, the parties agree as follows:

 

		1.	All capitalized terms not defined herein will have the meaning assigned to them in the Agreement.

	 	 	 
		2.	Section 2.1(b) of the Agreement is hereby amended and replaced in its entirety by the following:
	 	 	 

“In
addition to the Initial Closing pursuant to Section 2.1(a) above, the Company and the Purchasers agree that the Purchasers,
and any one of the Purchasers, may purchase in their sole discretion up to an aggregate of 70,000,000 of Shares at the Per Share
Purchase Price (up to $14,000,000) in a subsequent closing or series of subsequent closings (each, a “Subsequent Closing”);
provided that such Subsequent Closing(s) occur on or before February 20, 2014, on the same terms and conditions as set forth herein,
and provided further that the Articles Amendment (as defined in Section 3.1(g)(iii)) of this Agreement is duly adopted by
the Company’s Board of Directors and shareholders and filed with the Secretary of State of Colorado.”

	 	 	 
		3.	Except as amended by this Amendment, the terms and conditions of the Agreement shall remain in
full force and effect.

 

[Signature Page Follows]

 

    	 

    	 

    

 

 

 

IN WITNESS WHEREOF, the parties hereto have
executed this Amendment to Stock Purchase Agreement as of the day and year first above written.

 

“COMPANY”

 

REVEN HOUSING REIT, INC.

a Colorado corporation

 

 

By:  /s/ Chad Carpenter

Name:
Chad Carpenter

Title:
Chief Executive Officer

 

 

“PURCHASERS”

 

 

 

King
Apex Group Holdings II Limited

 

 

By:  /s/ Xiaofan Bai

Name:
Xiaofan Bai

Title:
Manager

 

 

King
Apex Group Holdings III Limited

 

 

By:   /s/ Xiaofan Bai

Name:
Xiaofan Bai

Title:
ManagerEXHIBIT 10.2

 

SECOND AMENDMENT TO

SINGLE FAMILY HOMES REAL ESTATE PURCHASE
AND SALE AGREEMENT

 

 

THIS SECOND AMENDMENT
TO SINGLE FAMILY HOMES REAL ESTATE PURCHASE AND SALE AGREEMENT (this "Second Amendment") is made as of December 23,
2013, by and between RED DOOR HOUSING LLC, a Texas limited liability company and WFI
FUNDING, INC., a Texas corporation d/b/a RED DOOR FUNDING (collectively, “Seller”), and REVEN
HOUSING TEXAS, LLC, a Delaware limited liability company (“Buyer”) with reference to the following
recitals:

 

RECITALS

 

A.Seller and
Assignor entered into that certain Single Family Homes Real Estate Purchase and Sale Agreement, dated as of October 4, 2013 ("Original
Agreement"), as amended by that certain First Amendment to Single Family Homes Real Estate Purchase Agreement (“First
Amendment,” and collectively with the Original Agreement, the “Agreement”), pursuant
to which Seller agreed to sell and Assignor agreed to purchase from Seller, that certain group of One Hundred Seventy (170)
single family homes, in the City of Houston, Texas, and which is more particularly defined in the Agreement as the “Property,”
all upon the terms and subject to the conditions contained in the Agreement.

 

B.Seller and Assignor have agreed
to further amend the Agreement to reflect the scheduled closing dates, as set forth herein.

 

AGREEMENT

 

1.                 
Definitions. All initially-capitalized terms used in this Second Amendment without definition shall have the meanings
given such terms in the Agreement.

 

2.                 
Closing Dates. Section 5(d) of the Agreement is hereby amended to delete the final sentence of that Section (as Amended
in the First Amendment) and replace that sentence with the following:

 

Buyer may, in its discretion,
close on the properties identified on Exhibit A-2 by delivering to Escrow the sum of the values of the properties set forth
on Exhibit A-2 (less the value of any Excluded Properties) on or before February 28, 2014, and the consideration required
to close with respect to those Properties will be the amount so delivered to Escrow.

 

A copy of ExhibitA-2 is
attached to this Second Amendment for reference purposes, but remains unchanged from Exhibit A-2 attached to the First Amendment.

 

3.                 
Representations and Warranties. Section 6(a) of the Agreement is hereby amended to add the following paragraph 13:

 

(13) Options to Purchase. To Seller’s Knowledge,
no tenant that is a party to a Lease has any right or option to purchase the Property that has not been expressly disclosed to
Buyer.

 

    	 

    	 

    

 

 

4.                 
Post-Closing Inspections. The first sentence of Section 7(d) of the Agreement is hereby amended to change the time
period during which Buyer may inspect the Properties after the Closing from 90 days to 150 days after the Closing.

 

5.                 
Property Exchange. Buyer and Seller agree that Seller will convey to Buyer the property located at 304 Highland Drive,
in Hitchcock, Texas, and in exchange Buyer will convey to Seller the property that Buyer acquired from Seller located at 3217 Washington,
in Pasadena, Texas (collectively, such conveyances are defined as the “Exchange”). The Exchange must
be completed on or before December 31, 2013. No consideration will be paid in connection with the Exchange, but Seller will pay
all title policy and escrow fees associated with the Exchange, and one-half of all other costs or expenses incurred by Buyer, including
the costs to file any disclosure documents necessitated by the Exchange. The Exchange will not affect the terms of the Agreement
with respect to the acquisition of the remaining properties identified on Exhibit A-2.

 

6.                 
Full Force and Effect. Except as modified herein, Buyer, Seller, and Assignor hereby agree and affirm that the Agreement
remains in full force and effect.

 

IN WITNESS WHEREOF, Buyer, and Seller have
caused this Second Amendment to be duly executed as of the day and year stated above.

 

	 	 

 

	BUYER:	
        REVEN HOUSING TEXAS, LLC,

        a Delaware limited liability company

         

         

        

        By: /s/ Chad Carpenter

        Name: Chad Carpenter

        Its: Chief Executive Officer

        

	 	 
	SELLER:	
        RED DOOR HOUSING, LLC,

        a Texas limited liability company

         

         

        

        By: /s/ Rickey Williams

        Name: Rickey Williams

        Its: President

        

	 	 
	SELLER:	
        WFI FUNDING, INC.,

        a Texas corporation

         

         

        

        By: /s/ Rickey Williams

        Name: Rickey Williams

        Its: President

        

 

 

    	 

    	 

    

 

 

EXHIBIT
A-2

 

DESCRIPTION
OF DEFERRED PROPERTies

 

	 	 	 	Address	 	Zip	 	 	Bed	 	 	Bath	 	 	Sq. Ft	 	 	RVEN Price	 
	 	1	 	 	27th 4801	 	 	77539	 	 	 	2	 	 	 	2	 	 	 	1162	 	 	$	63,211.45	 
	 	2	 	 	34th St 4903	 	 	77539	 	 	 	3	 	 	 	2	 	 	 	1386	 	 	$	71,963.80	 
	 	3	 	 	Belarbor 6315	 	 	77087	 	 	 	3	 	 	 	1	 	 	 	975	 	 	$	60,780.24	 
	 	4	 	 	Camden 1307	 	 	77502	 	 	 	3	 	 	 	2	 	 	 	1141	 	 	$	79,743.67	 
	 	5	 	 	Charney 8714	 	 	77088	 	 	 	3	 	 	 	1	 	 	 	1140	 	 	$	69,046.35	 
	 	6	 	 	Crooked Creek 5458	 	 	77017	 	 	 	4	 	 	 	1.5	 	 	 	1509	 	 	$	72,936.28	 
	 	7	 	 	Denoron 4907	 	 	77048	 	 	 	3	 	 	 	1	 	 	 	1397	 	 	$	67,587.62	 
	 	8	 	 	Foxside 7011	 	 	77338	 	 	 	3	 	 	 	2	 	 	 	2097	 	 	$	92,385.96	 
	 	9	 	 	Maplemont 16339	 	 	77095	 	 	 	4	 	 	 	2	 	 	 	1545	 	 	$	92,385.96	 
	 	10	 	 	Paddington 6214	 	 	77085	 	 	 	4	 	 	 	2	 	 	 	1566	 	 	$	82,661.12	 
	 	11	 	 	Pinetex 7326	 	 	77396	 	 	 	4	 	 	 	2	 	 	 	1659	 	 	$	87,523.54	 
	 	12	 	 	Red Leaf 711	 	 	77090	 	 	 	4	 	 	 	2	 	 	 	2556	 	 	$	116,698.05	 
	 	13	 	 	Wavecrest 1607	 	 	77062	 	 	 	3	 	 	 	2	 	 	 	1836	 	 	$	116,698.05	 
	 	14	 	 	Whispering Willow 23311	 	 	77373	 	 	 	3	 	 	 	2	 	 	 	1209	 	 	$	82,661.12	 
	 	15	 	 	Whitchurch Way 13203	 	 	77015	 	 	 	3	 	 	 	2	 	 	 	1520	 	 	$	95,303.41	 
	 	16	 	 	White Gate Ln 11326	 	 	77069	 	 	 	5	 	 	 	2	 	 	 	2464	 	 	$	97,248.38	 
	 	17	 	 	Whitehall 214	 	 	77060	 	 	 	3	 	 	 	2	 	 	 	1220	 	 	$	86,551.06	 
	 	18	 	 	Willow Oak 7318	 	 	77521	 	 	 	3	 	 	 	2	 	 	 	1448	 	 	$	102,110.80	 
	 	19	 	 	Winding Trace 6827	 	 	77086	 	 	 	3	 	 	 	2	 	 	 	1318	 	 	$	81,202.40	 
	 	20	 	 	Wingdale Dr 15907	 	 	77082	 	 	 	3	 	 	 	2	 	 	 	1524	 	 	$	89,468.51	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	30672	 	 	$	1,708,167.78THE SECURITIES REPRESENTED BY THIS CERTIFICATE
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE
AND MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER APPLICABLE FEDERAL AND STATE SECURITIES
LAWS OR PURSUANT TO AN APPLICABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE ACT
AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT,
WHICH OPINION SHALL BE REASONABLY ACCEPTABLE TO THE ISSUER. 

 

	INNOVUS PHARMACEUTICALS, INC.
	 	 
	8% DEBENTURE
	 	 
	$350,000 	La Jolla, CA

 

Dated as of: December 23, 2013

 

In consideration of the receipt of $350,000,
the undersigned, Innovus Pharmaceuticals, Inc., a Nevada corporation (“Issuer”), hereby promises to pay, dated as of
December 23, 2013, by and between Issuer and Lourmarin Corporation Retirement Plan (“Debenture Holder”), at the address
of 5139 Pearlman Way, San Diego, CA 94131, on the Maturity Date (as hereinafter defined), the principal amount of Three Hundred
Fifty Thousand Dollars ($350,000), and interest shall accrue hereon from the date hereof and be payable as provided herein.

 

1. Terms of the Debenture. 

 

1.1  Interest; Interest Rate;
Repayment.

 

(a) This Debenture shall bear interest at
the rate of eight (8%) percent (the “Interest Rate”) per annum based on a 365-day year. Interest shall be payable on
the Maturity Date.

 

(b) The principal outstanding hereunder
shall be paid in full on August 31st, 2014 (the “Maturity Date”).

 

(c) The principal amount and interest thereon
can be prepaid in whole or in part by the Issuer any time before the maturity date.

 

(d) All monetary payments to be made by
Issuer hereunder shall be made in lawful money of the United States by check or wire transfer of immediately available funds.

 

(e) If all or a portion of the principal
amount of this Debenture or any interest payable thereon shall not be repaid when due, whether on the Maturity Date, by acceleration
or otherwise, such overdue amounts shall bear interest at a rate per annum that is five percent (5%) above the Interest Rate (i.e.,
13%) from the date of such non-payment until such amount is paid in full (as well after as before judgment).

 

1.2 Other Assurances. Issuer shall
not, by amendment of its Articles of Incorporation or By-laws or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issuance or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms to be observed or performed hereunder by Issuer, but shall at all times in good faith assist in the carrying
out of all the provisions of this Debenture and in taking of all such actions as may be necessary or appropriate in order to protect
the rights of the Debenture Holder herein against impairment.

 

2. Events of Default. If
any of the following events (each, an “Event of Default”) shall occur and be continuing:

 

    	 

    	 

    

 

(i) Issuer shall fail to pay any amount
payable under this Debenture, including but limited to installments of interest and/or principal, within three (3) business days
after such payment becomes due (at the Maturity Date, an Interest Payment Date or other date) in accordance with the terms hereof;

 

(ii) Issuer shall fail to pay when due (following
the expiration of applicable notice and cure periods), whether upon acceleration, prepayment obligation or otherwise, any indebtedness
for money due, individually or in the aggregate, involving an amount in excess of $50,000;

 

(iii) Any representation, warranty, covenant
or agreement made by Issuer that this Debenture was incorrect in any material respect on or as of the date made;

 

(iv) Issuer shall default, in any material
respect, in the observance or performance of any other agreement contained in this Debenture or any other agreement or instrument
contemplated by this Debenture, and such default shall continue unremedied for a period of fifteen (15) days after written notice
to Issuer of such default;

 

(v) (a) Issuer shall commence any case,
proceeding or other action (x) under any existing or future law of any jurisdiction, domestic or foreign, relating to bankruptcy,
insolvency, reorganization, conservatorship or relief of debtors, seeking to have an order for relief entered with respect to it,
or seeking to adjudicate it a bankrupt or insolvent, or seeking reorganization, arrangement, adjustment, winding-up, liquidation,
dissolution, composition or other relief with respect to it or its debts, or (y) seeking appointment or a receiver, trustee, custodian,
conservator or other similar official for it or for all or any substantial part of its assets, or Issuer shall make a general assignment
for the benefit of its creditors; or (b) there shall be commenced against Issuer any case, proceeding or other action of a nature
referred to in clause (a) above that (A) results in the entry of an order for relief of any such adjudication of appointment or
(B) remains undismissed, undischarged or unbonded for a period of ninety (90) days; or (c) there shall be commenced against Issuer
any case, proceeding other action seeking issuance of a warrant of attachment, execution, distrait or similar process against all
or any substantial part of its assets that results in the entry of an order for any such relief which shall not have been vacated,
discharged, or stayed or bonded pending appeal within ninety (90) days from the entry thereof; or (d) Issuer shall take any action
in furtherance of, or indicating its consent to, approval of, or acquiescence in any of the acts set forth in clauses (a), (b)
or (c) above; or (e) Issuer shall generally not, or shall be unable to, or shall admit in writing its inability to, pay its debts
as they become due then, and in any such event, (x) if such event is an Event of Default specified in subsection (v) above of this
Section 2, automatically this Debenture (with all accrued and unpaid interest thereon) and all other amounts owing under this Debenture
shall immediately become due and payable, and (y) if such event is any other Event of Default, the Debenture Holder may, by written
notice to Issuer, declare this Debenture (with all accrued and unpaid interest thereon) and all other amounts owing under this
Debenture to be due and payable forthwith, whereupon the same shall immediately become due and payable. Except as expressly provided
above in this Section 2, presentation, demand, protest and all other notices of any kind are hereby expressly waived by Issuer.

 

3. MISCELLANEOUS. 

 

3.1 Interest Rate. Any interest
payable hereunder that is in excess of the maximum interest rate permitted under applicable law shall be reduced to the maximum
interest rate permitted under such applicable law.

 

3.2 Notices. All notices and other
communications hereunder shall be in writing and shall be deemed to have been given when delivered by hand or by facsimile transmission,
when telexed, or upon receipt when mailed by registered or certified mail (return receipt requested), postage prepaid, to the
parties at the following addresses (or at such other address for a party as shall be specified by like notice):

 

If to Issuer:

 

Innovus Pharmaceuticals, Inc.

4275 Executive Square, Suite 200

La Jolla, CA 92037

Attn: Bassam Damaj

Facsimile: (858) 964-2301

 

    	 

    	 

    

 

With a copy (which copy shall not constitute notice) to:

 

Innovus Pharmaceuticals, Inc.

4275 Executive Square, Suite 200

La Jolla, CA 92037

Attn: Legal Department

Facsimile: (858) 964-2301

 

If to Debenture Holder: at its address
as furnished on the face of this Debenture.

 

3.3 Entire Agreement; Exercise of Rights.

 

(a) This Debenture embodies the entire agreement and understanding
of the parties hereto with respect to the subject matter hereof. No amendment of any provision of this Debenture shall be effective
unless it is in writing and signed by each of the parties; and no waiver of any provision of this Debenture, nor consent to any
departure by either party from it, shall be effective unless it is in writing and signed by the affected party, and then such waiver
or consent shall be effective only in the specific instance and for the specific purpose for which given.

 

(b) No failure on the part of a party to exercise, and no delay
in exercising, any right under this Debenture, or any agreement contemplated hereby, shall operate as a waiver hereof by such party,
nor shall any single or partial exercise of any right under this Debenture, or any agreement contemplated hereby, preclude any
other or further exercise thereof or the exercise of any other right.

 

3.4 Personal Guarantee of Debenture.
Dr. Bassam Damaj, in his personal capacity, will guarantee the payment of the principal and interest under this Debenture to the
Debenture Holder if any Event of Default occurs hereunder.

 

3.5 Governing Law. This Debenture
shall be governed by and construed in accordance with the laws of the State of California applicable to agreements made and to
be performed entirely within such state, without regards to its conflicts of law provisions.

 

3.6 Transferability. This Debenture
shall not be transferable in any manner without the express written consent of Issuer, which consent may not be unreasonably withheld.
 

 

*********************

 

    	 

    	 

    

 

IN WITNESS WHEREOF, the parties hereto have
executed this Debenture on the date first above written.

 

	 	INNOVUS PHARMACEUTICALS, INC. 
	 	 
	 	By: 	/s/ Bassam Damaj
	 	 	Name: Bassam Damaj, Ph.D.
	 	 	Title: President & Chief Executive Officer
	 	 	 
	 	DEBENTURE HOLDER 
	 	 	 
	 	By:	Lourmarin
Corporation Retirement Plan
	 	 	Lourmarin Corporation Retirement Plan
	 	 	 
	 	Name:	/s/ Shaun Burnett
	 	Its:	Trustee
	 	Date:	12/23/13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00225-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00225-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00225-of-00352.parquet"}]]